Hyperalgesia
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
×
CUI:
C0030193
Disease:
Pain
Pain
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Pain, Burning
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
×
CUI:
C0234238
Disease:
Ache
Ache
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Radiating pain
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Allodynia
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Pain, Splitting
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Pain, Crushing
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Hyperalgesia, Primary
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Hyperalgesia, Secondary
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Tactile Allodynia
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Hyperalgesia, Thermal
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Pain, Migratory
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Suffering, Physical
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
Mechanical Allodynia
0.300
Biomarker
phenotype
CTD_human
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
21151121
2011
ovarian neoplasm
0.310
Biomarker
disease
CTD_human
Analysis of HOXD1 , MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development.
20852632
2010
Malignant neoplasm of ovary
0.310
Biomarker
disease
CTD_human
Analysis of HOXD1 , MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development.
20852632
2010
Colorectal Carcinoma
0.300
Biomarker
disease
CTD_human
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.
17892325
2007
Colorectal Neoplasms
0.300
Biomarker
group
CTD_human
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.
17892325
2007
Neoplasm Metastasis
0.010
Biomarker
phenotype
BEFREE
Furthermore, RNPC1 overexpression restrained the promotion of STARD13, CDH5, HOXD10, and HOXD1 knockdown on cell metastasis .
29733656
2018
Glucose tolerance test
0.100
GeneticVariation
phenotype
GWASCAT
Genetic determinants of circulating GIP and GLP-1 concentrations.
29093273
2017
Neuroblastoma
0.010
AlteredExpression
disease
BEFREE
However, a significant induction of HOXC6, HOXD1 , and HOXD8 expression is seen in the RA-treated NB cell lines, albeit with different patterns and degree of up-regulation. db-cAMP treatment also induced HOXC6 and HOXD8 expression in two of the three NB cell lines analyzed.
7501971
1996
Central neuroblastoma
0.010
AlteredExpression
disease
BEFREE
However, a significant induction of HOXC6, HOXD1 , and HOXD8 expression is seen in the RA-treated NB cell lines, albeit with different patterns and degree of up-regulation. db-cAMP treatment also induced HOXC6 and HOXD8 expression in two of the three NB cell lines analyzed.
7501971
1996
Childhood Neuroblastoma
0.010
AlteredExpression
disease
BEFREE
However, a significant induction of HOXC6, HOXD1 , and HOXD8 expression is seen in the RA-treated NB cell lines, albeit with different patterns and degree of up-regulation. db-cAMP treatment also induced HOXC6 and HOXD8 expression in two of the three NB cell lines analyzed.
7501971
1996
Glomerular Filtration Rate
0.100
GeneticVariation
phenotype
GWASCAT
Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis.
31015462
2019